HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Nemaline myopathy 1

Also Known As:

Cap Myopathy, Tpm3-Related; Nemaline myopathy caused by mutation in the tropomyosin 3 gene

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Musculoskeletal Diseases: 719
- Muscular Diseases: 10128
  - Congenital Structural Myopathies: 407
    - Nemaline Myopathies: 331
      - Nemaline myopathy 1: 1
Nervous System Diseases: 14178
- Neuromuscular Diseases: 2005
  - Muscular Diseases: 10128
    - Congenital Structural Myopathies: 407
      - Nemaline Myopathies: 331
        Nemaline myopathy 1: 1

Related Diseases

1.	Congenital Structural Myopathies (Centronuclear Myopathy)
2.	Muscular Diseases (Myopathy)
3.	Cap Myopathy

Experts

1.	Bevilacqua, Jorge A: 1 article (01/2022)
2.	Brochier, Guy: 1 article (01/2022)
3.	Campero, Mario: 1 article (01/2022)
4.	Contreras, Juan Pablo: 1 article (01/2022)
5.	Díaz, Jorge: 1 article (01/2022)
6.	Hernández, Úrsula: 1 article (01/2022)
7.	Hughes, Ricardo: 1 article (01/2022)
8.	Romero, Norma B: 1 article (01/2022)
9.	Trangulao, Alejandra: 1 article (01/2022)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Nemaline myopathy 1:

1.	TropomyosinIBA 01/01/2022 - "Tropomyosin 3 (TPM3) gene mutations associate with autosomal dominant and recessive nemaline myopathy 1 (NEM1), congenital fiber type disproportion myopathy (CFTD) and cap myopathy (CAPM1), and a combination of caps and nemaline bodies. "